Therefore, the present study focused on the regulation of the PI3K/AKT signaling pathway and macrophage polarization by SORBS1 to inhibit EMT in breast cancer, with the aim of discovering potential drug targets for the clinical treatment of this disease. The gene discussed is SORBS1; the disease is breast cancer.